Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool

The main objective of this investigation was to develop an in vitro–in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studi...

Full description

Bibliographic Details
Authors: Figueroa-Campos, Andrés Ignacio; Sánchez-Dengra, Bárbara; Merino, Virginia; Dahan, Arik; Gonzalez-Alvarez, Isabel; García Arieta, Alfredo; Gonzalez-Alvarez, Marta; Bermejo, Marival
Format: Article
Publication date:2020
Country:España
Institution:Universidad Miguel Hernández de Elche
Repository:REDIUMH. Depósito Digital de la UMH
OAI Identifier:oai:dspace.umh.es:11000/34728
Online Access:https://hdl.handle.net/11000/34728
Access Level:Open access
Keyword:candesartan cilexetil
IVIVC
bioequivalence
BCS
predictive in vivo-dissolution
CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología
_version_ 1878733202885967872
author Figueroa-Campos, Andrés Ignacio
author2 Sánchez-Dengra, Bárbara
Merino, Virginia
Dahan, Arik
Gonzalez-Alvarez, Isabel
García Arieta, Alfredo
Gonzalez-Alvarez, Marta
Bermejo, Marival
author2_role author
author
author
author
author
author
author
author_browse Bermejo, Marival
Dahan, Arik
Figueroa-Campos, Andrés Ignacio
García Arieta, Alfredo
Gonzalez-Alvarez, Isabel
Gonzalez-Alvarez, Marta
Merino, Virginia
Sánchez-Dengra, Bárbara
author_facet Figueroa-Campos, Andrés Ignacio
Sánchez-Dengra, Bárbara
Merino, Virginia
Dahan, Arik
Gonzalez-Alvarez, Isabel
García Arieta, Alfredo
Gonzalez-Alvarez, Marta
Bermejo, Marival
author_role author
collection REDIUMH. Depósito Digital de la UMH
description The main objective of this investigation was to develop an in vitro–in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studies. Data from two bioequivalence studies were scaled and combined to obtain the dataset for the IVIVC. Two-step and one-step approaches were used to develop the IVIVC. Experimental solubility and permeability data confirmed candesartan cilexetil. Biopharmaceutic Classification System (BCS) class II candesartan average plasma profiles were deconvoluted by the Loo-Riegelman method to obtain the oral fractions absorbed. Fractions dissolved were obtained in several conditions in USP II and IV apparatus and the results were compared calculating the f2 similarity factor. Levy plot was constructed to estimate the time scaling factor and to make both processes, dissolution and absorption, superimposable. The in vitro dissolution experiment that reflected more accurately the in vivo behavior of the products of candesartan cilexetil employed the USP IV apparatus and a three-step pH buffer change, from 1.2 to 4.5 and 6.8, with 0.2% of Tween 20. This new model was able to predict the in vivo differences in dissolution and it could be used as a risk-analysis tool for formulation selection in future bioequivalence trials.
eu_rights_str_mv openAccess
format article
id ES_51db0b79162f082c32a6084c74eec708
institution Universidad Miguel Hernández de Elche
instname_str Universidad Miguel Hernández de Elche
network_acronym_str ES
network_name_str España
oai_identifier_str oai:dspace.umh.es:11000/34728
publishDate 2020
publishDateSort 2020
publisher MDPI
publisherStr MDPI
reponame_str REDIUMH. Depósito Digital de la UMH
spelling Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool Figueroa-Campos, Andrés Ignacio Sánchez-Dengra, Bárbara Merino, Virginia Dahan, Arik Gonzalez-Alvarez, Isabel García Arieta, Alfredo Gonzalez-Alvarez, Marta Bermejo, Marival candesartan cilexetil IVIVC bioequivalence BCS predictive in vivo-dissolution CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología The main objective of this investigation was to develop an in vitro–in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studies. Data from two bioequivalence studies were scaled and combined to obtain the dataset for the IVIVC. Two-step and one-step approaches were used to develop the IVIVC. Experimental solubility and permeability data confirmed candesartan cilexetil. Biopharmaceutic Classification System (BCS) class II candesartan average plasma profiles were deconvoluted by the Loo-Riegelman method to obtain the oral fractions absorbed. Fractions dissolved were obtained in several conditions in USP II and IV apparatus and the results were compared calculating the f2 similarity factor. Levy plot was constructed to estimate the time scaling factor and to make both processes, dissolution and absorption, superimposable. The in vitro dissolution experiment that reflected more accurately the in vivo behavior of the products of candesartan cilexetil employed the USP IV apparatus and a three-step pH buffer change, from 1.2 to 4.5 and 6.8, with 0.2% of Tween 20. This new model was able to predict the in vivo differences in dissolution and it could be used as a risk-analysis tool for formulation selection in future bioequivalence trials. MDPI https://hdl.handle.net/11000/34728
spellingShingle Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
Figueroa-Campos, Andrés Ignacio
candesartan cilexetil
IVIVC
bioequivalence
BCS
predictive in vivo-dissolution
CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología
title Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
title_full Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
title_fullStr Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
title_full_unstemmed Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
title_short Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
title_sort Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
topic candesartan cilexetil
IVIVC
bioequivalence
BCS
predictive in vivo-dissolution
CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología
topic_facet candesartan cilexetil
IVIVC
bioequivalence
BCS
predictive in vivo-dissolution
CDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnología
url https://hdl.handle.net/11000/34728